EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Assessment of glial fibrillary acidic protein and anti‐glial fibrillary acidic protein autoantibody concentrations and necrotising meningoencephalitis risk genotype in dogs with pug dog myelopathy

Cecilia Rohdin iD, Ingrid Ljungvall, Karin Hultin Jäderlund, Anna Svensson, Kerstin Lindblad-Toh, Jens Häggström

Veterinary Record · 15.06.2024 · 194 (12)

DOI: 10.1002/vetr.3895 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Record, online erschienen am 05.05.2024. Verfasst von Cecilia Rohdin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden. Hauptthemen laut MEDLINE: Dog Diseases, Meningoencephalitis, Autoantibodies, Glial Fibrillary Acidic Protein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sveland Foundation of Animal Health and Welfare, Thure F. and Karin Forsberg's Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pugs commonly present with thoracolumbar myelopathy, also known as pug dog myelopathy (PDM), which is clinically characterised by progressive signs involving the pelvic limbs, no apparent signs of pain and, often, incontinence. In addition to meningeal fibrosis and focal spinal cord destruction, histopathology has confirmed lymphohistiocytic infiltrates in the central nervous system (CNS) in a considerable number of pugs with PDM. Lymphohistiocytic CNS inflammation also characterises necrotising meningoencephalitis (NME) in pugs. This study aimed to investigate the potential contribution of an immunological aetiology to the development of PDM.

Methods

The concentrations of glial fibrillary acidic protein (GFAP) in serum and CSF and of anti‐GFAP autoantibodies in CSF were measured with an ELISA. In addition, a commercial test was used for genetic characterisation of the dog leukocyte antigen class II haplotype, which is associated with NME susceptibility.

Results

This study included 87 dogs: 52 PDM pugs, 14 control pugs, four NME pugs and 17 dogs of breeds other than pugs that were investigated for neurological disease (neuro controls). Anti‐GFAP autoantibodies were present in 15 of 19 (79%) of the PDM pugs tested versus six of 16 (38%) of the neuro controls tested ( p = 0.018). All 18 PDM pugs evaluated had detectable CSF GFAP. Serum GFAP was detected in two of three (67%) of the NME pugs and in two of 11 (18%) of the control pugs but not in any of the 40 tested PDM pugs. Male pugs heterozygous for the NME risk haplotype had an earlier onset of clinical signs (70 months) compared to male pugs without the risk haplotype (78 months) ( p = 0.036).

Limitations

The study was limited by the lack of healthy dogs of breeds other than pugs and the small numbers of control pugs and pugs with NME.

Conclusions

The high proportion of PDM pugs with anti‐GFAP autoantibodies and high CSF GFAP concentrations provide support for a potential immunological contribution to the development of PDM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesMeningoencephalitisAutoantibodiesGlial Fibrillary Acidic ProteinSpinal Cord DiseasesAnimalsDogsMaleFemaleGenotypeGenetic Predisposition to Disease

Substanzen

AutoantibodiesGlial Fibrillary Acidic Protein

Autor:innen und Institutionen

  • Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden.
  • Anicura, Albano Small Animal Hospital, Danderyd, Sweden.
  • Department of Companion Animal Clinical Sciences, Norwegian University of Life Sciences, Ås, Norway.
  • Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Broad Institute, Cambridge, Massachusetts, USA.

ORCID-Profile: Cecilia Rohdin

Förderung

  • Sveland Foundation of Animal Health and Welfare
  • Thure F. and Karin Forsberg's Research Foundation

Zitieren

APA

Rohdin, C., Ljungvall, I., Jäderlund, K. H., Svensson, A., Lindblad-Toh, K., & Häggström, J. (2024). Assessment of glial fibrillary acidic protein and anti‐glial fibrillary acidic protein autoantibody concentrations and necrotising meningoencephalitis risk genotype in dogs with pug dog myelopathy. Veterinary Record, 194(12). https://doi.org/10.1002/vetr.3895

Vancouver

Rohdin C, Ljungvall I, Jäderlund KH, Svensson A, Lindblad-Toh K, Häggström J. Assessment of glial fibrillary acidic protein and anti‐glial fibrillary acidic protein autoantibody concentrations and necrotising meningoencephalitis risk genotype in dogs with pug dog myelopathy. Veterinary Record. 2024;194(12). doi:10.1002/vetr.3895

BibTeX
@article{Rohdin2024,
  author = {Rohdin, Cecilia and Ljungvall, Ingrid and Jäderlund, Karin Hultin and Svensson, Anna and Lindblad-Toh, Kerstin and Häggström, Jens},
  title = {Assessment of glial fibrillary acidic protein and anti‐glial fibrillary acidic protein autoantibody concentrations and necrotising meningoencephalitis risk genotype in dogs with pug dog myelopathy},
  journal = {Veterinary Record},
  year = {2024},
  volume = {194},
  number = {12},
  doi = {10.1002/vetr.3895}
}
Kostenlos starten →